Kabakoff David S - Jun 20, 2025 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff
Stock symbol
NXTC
Transactions as of
Jun 20, 2025
Transactions value $
$0
Form type
4
Date filed
6/24/2025, 04:31 PM
Previous filing
Jun 21, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KABAKOFF DAVID S Director C/O NEXTCURE, INC., 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE /s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff 2025-06-24 0001024008

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +28.1K $0.00 28.1K Jun 20, 2025 Common Stock 28.1K $0.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 20, 2026 and the date of the 2026 Annual Meeting of Stockholders.